Cataga, Baby Girl 2 .
HRN: 22-94-27 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/24/2023
04/30/2023
IV
15mg
Q24
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes